Search

Search Constraints

You searched for: Author/Creator Marizzoni, Moira

Search Results

51. P2‐007: Longitudinal reproducibility of default‐mode network connectivity in healthy elderly participants: A multicentric resting‐state fMRI study. (1st July 2015)

52. P2‐174: Multi‐site hippocampal subfields reproducibility: A european 3T study. (1st July 2015)

53. P2‐188: Characterization of cognitive function with the cantab in individuals with amnestic mild cognitive impairment in relation to hippocampal volume, amyloid, and tau status: Preliminary baseline results from the PharmaCog/european‐ADNI study. (1st July 2015)

55. P2‐271: ADDIA, A MULTICENTER CLINICAL STUDY OF PROOF‐OF‐PERFORMANCE TO VALIDATE BLOOD‐BASED BIOMARKERS FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE (AD): THE STUDY PROTOCOL. (1st July 2006)

56. P2‐302: CSF Beta‐Amyloid‐ and APOE Ɛ4‐Related Decline in Episodic Memory Over 12 Months Measured using the Cantab in Individuals with Amnestic MCI: Results from the European ADNI Study. (1st July 2016)

57. P2‐370: AMYLOID‐PET FOR MYELIN IMAGING IN ALZHEIMER'S DISEASE. (1st July 2006)

58. P3‐056: Back‐Translation of EEG/ERP Markers from Amnestic MCI Patients to Healthy Young Volunteers in the Pharmacog Project. (1st July 2016)

59. P3‐057: Association Between EEG/ERP and CSF Markers in Prodromal Alzheimer's Disease in the Pharmacog Project. (1st July 2016)

60. P3‐101: CROSS‐SECTIONAL BIOMARKER CHARACTERIZATION OF MILD COGNITIVE IMPAIRMENT PATIENTS IN WP5 PHARMACOG/E‐ADNI STUDY. (1st July 2014)